Close Menu

research grant

The new Allen Frontiers Group has named four investigators to lead its first cohort of projects, and will launch two new investigative centers at Stanford and Tufts.

The grant is the second in the last six months that the Paul G. Allen Family Foundation has awarded to Chembio for diagnostics development.

The Swedish firm, a spinout of Lund University, will evaluate the array-based blood tests to confirm, rule out, and monitor the autoimmune disease.

The Collaborative African Genomics Network recently finished its second year of grant funding, hitting many of its milestones, and is already digging into the work for their third year.

CyVerse, the developers believe, better expresses the platform's capacity to provide data management and computation to researchers across multiple scientific disciplines.

The team will employ reverse vaccinology coupled with high-throughput genomics approaches, such as RNA-seq, to deliver the new vaccines within four years.

The European precision medicine project will use Agendia technology to subtype tumors and match patients with targeted therapies.

The consortium will analyze data from patients and mouse models in the first year as part of efforts to find ways of detecting tumors earlier.

The company will use the funds to design and test new 16S amplicon and sequencing approaches for exploring microbiomes.

Grants awarded to Chembio, BD, and FIND will help fund new diagnostic tests for Ebola and other fever-inducing illnesses and feasibility studies to evaluate them.

Pages

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.